Restricted accessLetterFirst published online 2023-10
Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome
Ruiz-IrastorzaGCrowtherMBranchW, et al.Antiphospholipid syndrome. Lancet2010; 376: 1498–1509.
2.
BohgakiMAtsumiTYamashitaY, et al.The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. Int Immunol2004; 16: 1633–1641.
3.
Vega-OstertagMCasperKSwerlickR, et al.Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum2005; 52: 1545–1554.
4.
OkuKAmengualOZigonP, et al.Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody. Rheumatology2013; 52: 1775–1784.
5.
KatoMAtsumiTOkuK, et al.The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Lupus2013; 22: 761–771.
6.
ReissABWanDWAnwarK, et al.Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis. Exp Biol Med2009; 234: 354–360.
7.
PelegriYCerratoGMartinuzzoME, et al.Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome. Clin Exp Rheumatol2003; 21: 221–224.
8.
RockGChauhanKJamiesonGA, et al.Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications. Br J Haematol1994; 88: 878–880.
9.
KaneshigeRNojimaJMotokiY, et al.aCL/β2GPI and aPS/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-α secretion by mononuclear cells. Thromb Res2019; 181: 52–58.
10.
SilversteinRL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med2009; 76(Suppl 2): S27–S30.
